United States News Todas as matérias

ABM Industries (NYSE:ABM), a global leader in facility services and integrated solutions, reported a solid start to its fiscal year 2026 on Tuesday, with first-quarter revenue reaching $2.2 billion.

Kohl’s (NYSE:KSS) reported a decline in both quarterly and annual sales on Tuesday, reflecting persistent pressure on middle-income households and a shifting retail landscape.

Medtronic (NYSE:MDT) announced a definitive agreement on Tuesday to acquire Scientia Vascular, a privately held medical technology firm specializing in high-performance access products for neurovascular procedures.

Lazard (NYSE:LAZ) reported a notable increase in its preliminary assets under management (AUM) for February 2026, reaching $277.7 billion.

NIO (NYSE:NIO), a pioneer in China’s premium smart electric vehicle market, reported strong financial results for the fourth quarter of 2025, marked by a decisive shift toward profitability.

LiveOne (NASDAQ:LVO), the music and entertainment technology platform, announced on Tuesday a multi-year extension of its global licensing partnership with Merlin, the preeminent digital rights solicitor for the independent music sector.

Esperion Therapeutics (NASDAQ:ESPR), the pharmaceutical company focused on lipid-management therapies, reported total revenue of $168.4 million for the fourth quarter, representing a 144% increase over the same period last year.

AT&T (NYSE:T) announced a landmark commitment on Tuesday to invest more than $250 billion through 2030, marking one of the largest infrastructure plays in the history of American telecommunications.

ChipMOS TECHNOLOGIES (NASDAQ:IMOS), a leading provider of outsourced semiconductor assembly and test services, reported unaudited consolidated revenue of NT$2,143.6 million (US$68.4 million) for February 2026.

Empresa Distribuidora y Comercializadora Norte (NYSE:EDN), commonly known as Edenor, reported a net income of $41.6 million for the fourth quarter on Monday.

Cosan (NYSE:CSAN), the Brazilian conglomerate with interests spanning sugar, ethanol, energy, and logistics, reported a net loss of $1.07 billion for the fourth quarter.

ASE Technology Holding (NYSE:ASX), the world’s largest provider of independent semiconductor manufacturing services in assembly and testing, reported unaudited consolidated net revenues of NT$52,097 million ($1,653 million) for February 2026.

Yalla Group (NYSE:YALA), the largest Middle East-focused social networking and gaming platform, reported unaudited fourth-quarter and full-year 2025 financial results that underscore its sector-leading profitability despite a cooling in its paying user base.

Genius Group (NYSE:GNS), an education technology company focused on entrepreneurial education and business incubation, on Monday reported audited financial results for the full year ended December 31, 2025, alongside a business update highlighting its reorganization and improving operational trajectory.

Spruce Biosciences (NASDAQ:SPRB) reported a significant reduction in annual operating expenses for 2025 on Monday, as the company successfully transitioned its clinical focus toward its enzyme replacement therapy for rare neurological disorders.

Hewlett Packard Enterprise (NYSE:HPE) reported third-quarter financial results that showcased a significant acceleration in top-line growth, fueled by robust demand for its "as-a-service" offerings and high-performance computing.

Yext (NYSE:YEXT), the New York-based software developer specializing in digital presence and search, reported a net income of $4.2 million for its fiscal fourth quarter on Monday.

Anthropic PBC filed two federal lawsuits Monday challenging the Pentagon’s decision to label the artificial intelligence startup a “supply chain risk,” an unprecedented move following the company’s refusal to permit unrestricted military use of its Claude chatbot.

Precision BioSciences (NASDAQ:DTIL) shares are in focus after the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD, an investigational in vivo gene editing therapy designed to treat Duchenne muscular dystrophy (DMD).

Boundless Bio (NASDAQ:BOLD) reported a narrowed net loss for the full year 2025 and a strategic realignment of its oncology pipeline, prioritizing a novel kinesin degrader as it prepares to enter the next phase of clinical development.

Hims & Hers Health (NYSE:HIMS) shares surged as much as 52% in early trading Monday after the telehealth leader announced a surprising end to its legal battle with Novo Nordisk.

Alexander’s (NYSE:ALX) on Monday announced it has entered into an agreement to sell its Rego Park I property in Queens, New York, to Northwell Health for a gross purchase price of $235.5 million.

Eltek (NASDAQ:ELTK), an Israeli manufacturer of technologically advanced printed circuit boards primarily serving defense, medical and industrial applications, on Monday reported full-year 2025 revenue of $51.8 million, an increase of 11% from the prior year.

American Express Global Business Travel (NYSE:GBTG) reported a transformative fourth quarter on Monday, as the integration of recent acquisition CWT propelled revenue up 34% to $792 million.